Pilot Proof of Concept Study Evaluating the Potential Psilocybin Assisted Psychotherapy (PAP) as a Therapeutic Tool for Patients Suffering From Severe Irritable Bowel Syndrome.
Phase: EARLY_PHASE1 | Sponsor: NYU Langone Health | Compound: Psilocybin
- Status
- planned
- Institution
- NYU Langone Health
- Start date
- 2025-08-01
- End date
- 2025-12-01
- Registry ID
- NCT06760533
Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.